0001209191-15-019896.txt : 20150228
0001209191-15-019896.hdr.sgml : 20150227
20150227183732
ACCESSION NUMBER: 0001209191-15-019896
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150227
FILED AS OF DATE: 20150227
DATE AS OF CHANGE: 20150227
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYLAN INC.
CENTRAL INDEX KEY: 0000069499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251211621
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 MYLAN BOULEVARD
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: 724-514-1800
MAIL ADDRESS:
STREET 1: 1000 MYLAN BOULEVARD
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: MYLAN LABORATORIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: FRM CORP
DATE OF NAME CHANGE: 19711003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHEEHAN JOHN D
CENTRAL INDEX KEY: 0001189331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09114
FILM NUMBER: 15661359
MAIL ADDRESS:
STREET 1: 5725 DELPHI DRIVE
CITY: TROY
STATE: MI
ZIP: 48098
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-02-27
1
0000069499
MYLAN INC.
MYL
0001189331
SHEEHAN JOHN D
1000 MYLAN BLVD
CANONSBURG
PA
15317
0
1
0
0
EVP and CFO
Common Stock
2015-02-27
4
D
0
138318
D
0
D
Employee Stock Option - Right to Buy
22.66
2015-02-27
4
D
0
13239
D
2021-03-02
Common Stock
13239
0
D
Employee Stock Option - Right to Buy
23.44
2015-02-27
4
D
0
4266
D
2022-02-22
Common Stock
4266
0
D
Employee Stock Option - Right to Buy
30.90
2015-02-27
4
D
0
3236
D
2023-03-06
Common Stock
3236
0
D
Employee Stock Option - Right to Buy
55.84
2015-02-27
4
D
0
17740
D
2024-03-05
Common Stock
17740
0
D
On February 27, 2015 (the "Closing Date"), Mylan N.V. completed the transaction (the "Transaction") by which it acquired Mylan Inc. and Abbott Laboratories' ("Abbott") non-U.S. developed markets specialty and branded generics business (the "Business"). Pursuant to the terms of the Amended and Restated Business Transfer Agreement and Plan of Merger, dated as of November 4, 2014, by and among Mylan Inc., New Moon B.V. (which has been renamed Mylan N.V. and is referred to herein as "Mylan"), Moon of PA Inc. ("Merger Sub"), and Abbott, on the Closing Date, Mylan acquired the Business and Merger Sub merged with and into Mylan Inc., with Mylan Inc. surviving as a wholly owned indirect subsidiary of Mylan and each share of Mylan Inc. common stock issued and outstanding was cancelled and automatically converted into and became the right to receive one Mylan ordinary share (the "Merger"). (Continued in Footnote 2)
In connection with the Transaction, Mylan Inc. and the Business have been reorganized under Mylan, a new public company organized in the Netherlands. This report is being filed by the reporting person solely to report the disposition of shares of Mylan Inc. common stock in connection with the Transaction. The reporting person will file a separate Form 4 to reflect the corresponding acquisition of securities of Mylan in connection with the Transaction.
Represents shares of Mylan Inc. common stock that were exchanged on a one-for-one basis for Mylan ordinary shares in connection with the Transaction. On the effective date of the Merger, the closing price of MYL was $57.33 per share.
Represents stock options of Mylan Inc. common stock that were exchanged for stock options of Mylan ordinary shares having substantially the same terms in connection with the Transaction.
These options vested on March 2, 2014.
These options vested on February 22, 2015.
These options vest on March 6, 2016.
These options vest in three equal annual installments beginning on March 5, 2015.
/s/ Bradley L. Wideman, by power of attorney
2015-02-27